These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38509141)

  • 1. MiRNA-296-5p promotes the sensitivity of nasopharyngeal carcinoma cells to cisplatin via targeted inhibition of STAT3/KLF4 signaling axis.
    Luo HQ; Wang Y; Ren J; Zhang QY; Chen Y; Chen MH; Huang NX; Wu MH; Tang XD; Li XY
    Sci Rep; 2024 Mar; 14(1):6681. PubMed ID: 38509141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOTAIR mediates cisplatin resistance in nasopharyngeal carcinoma by regulating miR-106a-5p/SOX4 axis.
    Cao W; Sun Y; Liu L; Yu J; Ji J; Wang Y; Yang J
    Bioengineered; 2022 Mar; 13(3):6567-6578. PubMed ID: 35227173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met.
    Lin FJ; Lin XD; Xu LY; Zhu SQ
    Mol Cells; 2020 Oct; 43(10):856-869. PubMed ID: 33115978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-302c-5p affects the stemness and cisplatin resistance of nasopharyngeal carcinoma cells by regulating HSP90AA1.
    Zhou X; Zheng L; Zeng C; Wu Y; Tang X; Zhu Y; Tang S
    Anticancer Drugs; 2023 Jan; 34(1):135-143. PubMed ID: 36539366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
    Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
    Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
    BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA LINC00346 contributes to cisplatin resistance in nasopharyngeal carcinoma by repressing miR-342-5p.
    Cui Z; Pu T; Zhang Y; Wang J; Zhao Y
    Open Biol; 2020 May; 10(5):190286. PubMed ID: 32397872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B.
    Zhao Y; Wang P; Wu Q
    Mol Cell Probes; 2020 Oct; 53():101597. PubMed ID: 32407879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulated long non-coding RNA SNHG7 restricts proliferation and boosts apoptosis of nasopharyngeal carcinoma cells by elevating microRNA-140-5p to suppress GLI3 expression.
    Dai Y; Zhang X; Xing H; Zhang Y; Cao H; Sang J; Gao L; Wang L
    Cell Cycle; 2020 Feb; 19(4):448-463. PubMed ID: 31944163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-101-3p inhibits nasopharyngeal carcinoma cell proliferation and cisplatin resistance through ZIC5 down-regulation by targeting SOX2.
    Li T; Zhang G; Li W; Xiao J; Zhou Z; Tan G; Ai J
    Biol Chem; 2023 Sep; 404(10):961-975. PubMed ID: 36752150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory Mechanism of lncRNA CTBP1-AS2 in Nasopharyngeal Carcinoma Cell Proliferation and Apoptosis via the miR-140-5p/BMP2 Axis.
    Huang B; Li Y; Deng Z; Lan G; Si Y; Zhou Q
    Protein Pept Lett; 2022; 29(7):621-630. PubMed ID: 35894463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA SET domain protein 3 promotes nasopharyngeal carcinoma proliferation, cisplatin resistance, and protein kinase B / mammalian target of rapamycin pathway activation by modulating microRNA-147a expression.
    Deng G; Wang F; Song Y
    Bioengineered; 2022 Mar; 13(3):5843-5854. PubMed ID: 35196205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG7 promotes the proliferation of nasopharyngeal carcinoma by miR-514a-5p/ELAVL1 axis.
    Hu W; Li H; Wang S
    BMC Cancer; 2020 May; 20(1):376. PubMed ID: 32370736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircNRIP1 Modulates the miR-515-5p/IL-25 Axis to Control 5-Fu and Cisplatin Resistance in Nasopharyngeal Carcinoma.
    Lin J; Qin H; Han Y; Li X; Zhao Y; Zhai G
    Drug Des Devel Ther; 2021; 15():323-330. PubMed ID: 33536745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma.
    Liu Z; Cheng C; Luo X; Xia Q; Zhang Y; Long X; Jiang Q; Fang W
    BMC Cancer; 2016 Mar; 16():238. PubMed ID: 26993269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal transfer of miR-106a-5p contributes to cisplatin resistance and tumorigenesis in nasopharyngeal carcinoma.
    Li J; Hu C; Chao H; Zhang Y; Li Y; Hou J; Huang L
    J Cell Mol Med; 2021 Oct; 25(19):9183-9198. PubMed ID: 34469038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-30e-5p inhibits the migration and invasion of nasopharyngeal carcinoma via regulating the expression of MTA1.
    Hu W; Yao W; Li H; Chen L
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32458989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.
    Shao Q; Zhang P; Ma Y; Lu Z; Meng J; Li H; Wang X; Chen D; Zhang M; Han Y; Liu H; Ma S
    Gene; 2018 Apr; 652():48-58. PubMed ID: 29427737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of miR-34c-5p inhibits nasopharyngeal carcinoma cells by mediating NOTCH1.
    Xu X; Yan H; Zhang L; Liu J; Huang Y; Cheng H
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32458967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasopharyngeal carcinoma derived exosomes regulate the proliferation and migration of nasopharyngeal carcinoma cells by mediating the miR-99a-5p BAZ2A axis.
    Zhou XJ; Xu HM; Huang GS; Lin BR
    Braz J Otorhinolaryngol; 2024; 90(1):101343. PubMed ID: 37925811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.